Immunogenicity of the UK group B meningococcal vaccine (4CMenB) schedule against groups B and C meningococcal strains (Sched3): outcomes of a multicentre, open-label, randomised controlled trial.
Saved in:
| Title: | Immunogenicity of the UK group B meningococcal vaccine (4CMenB) schedule against groups B and C meningococcal strains (Sched3): outcomes of a multicentre, open-label, randomised controlled trial. |
|---|---|
| Authors: | Davis, Kimberly1 (AUTHOR), Valente Pinto, Marta1 (AUTHOR), Andrews, Nick J2 (AUTHOR), Goldblatt, David3 (AUTHOR), Borrow, Ray4 (AUTHOR), Findlow, Helen4 (AUTHOR), Southern, Jo5 (AUTHOR), Partington, Jo1 (AUTHOR), Plested, Emma1 (AUTHOR), Patel, Sima4 (AUTHOR), Holland, Ann4 (AUTHOR), Matheson, Mary6 (AUTHOR), England, Anna6 (AUTHOR), Hallis, Bassam6 (AUTHOR), Miller, Elizabeth5 (AUTHOR), Snape, Matthew D1,7 (AUTHOR) matthew.snape@paediatrics.ox.ac.uk |
| Source: | Lancet Infectious Diseases. May2021, Vol. 21 Issue 5, p688-696. 9p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
